Stockscreener 앱 받기
8.89
0.45%
-0.04
시간 외 거래:
8.81
-0.08
-0.90%
전일 마감가:
$8.93
열려 있는:
$8.95
하루 거래량:
794.56K
Relative Volume:
0.55
시가총액:
$1.20B
수익:
$175.51M
순이익/손실:
$-78.02M
주가수익비율:
-16.77
EPS:
-0.53
순현금흐름:
$-34.18M
1주 성능:
+3.13%
1개월 성능:
+2.89%
6개월 성능:
+7.89%
1년 성능:
+56.51%
1일 변동 폭
$8.80
$8.96
1주일 범위
$8.55
$9.36
52주 변동 폭
$5.195
$10.67
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
명칭
Aurinia Pharmaceuticals Inc
전화
250-744-2487
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
8.89 | 1.21B | 175.51M | -78.02M | -34.18M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-05 | 개시 | Cowen | Outperform |
| 2020-01-10 | 개시 | Jefferies | Buy |
| 2019-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-16 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 개시 | RBC Capital Mkts | Outperform |
| 2017-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 재확인 | FBR & Co. | Outperform |
| 2016-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-30 | 개시 | H.C. Wainwright | Buy |
| 2015-05-08 | 개시 | MLV & Co | Buy |
모두보기
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
What makes Aurinia Pharmaceuticals Inc. stock price move sharplyEarnings Report Picks With High Returns - jammulinksnews.com
Does Aurinia Pharmaceuticals Inc. stock perform well during market downturnsSuperior portfolio returns - jammulinksnews.com
What is Aurinia Pharmaceuticals Inc. company’s growth strategyAchieve breakthrough profits with expert advice - jammulinksnews.com
Why is Aurinia Pharmaceuticals Inc. stock attracting strong analyst attentionMaximize your portfolio’s earning power - jammulinksnews.com
What is the risk reward ratio of investing in Aurinia Pharmaceuticals Inc. stockGet professional advice for market timing - jammulinksnews.com
Is Aurinia Pharmaceuticals Inc. a growth stock or a value stockAchieve breakthrough investment performance - jammulinksnews.com
Should I hold or sell Aurinia Pharmaceuticals Inc. stock in 2025Skyrocketing returns - jammulinksnews.com
Can Aurinia Pharmaceuticals Inc. stock recover from recent decline200 Percent Gain Alert - metal.it
Aurinia Pharmaceuticals Inc. Stock Analysis and ForecastFastest-growing stock picks - PrintWeekIndia
Will Aurinia Pharmaceuticals Inc. stock split in the near futureMarket-leading growth rates - jammulinksnews.com
What analysts say about Aurinia Pharmaceuticals Inc. stockRapid growth opportunities - Autocar Professional
When is the best time to buy Aurinia Pharmaceuticals Inc. stockSuperior profit margins - jammulinksnews.com
Is Aurinia Pharmaceuticals Inc. a good long term investmentTremendous gains - PrintWeekIndia
What drives Aurinia Pharmaceuticals Inc. stock priceUnmatched profit growth - Autocar Professional
Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - Zenopa
Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Aurinia Pharmaceuticals: LUPKYNIS Growth and AUR200 Pipeline Fuel Long-Term Value - AInvest
ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Yahoo.co
(AUPH) Technical Data - news.stocktradersdaily.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) Delivers Shareholders Favorable 52% Return Over 1 Year, Surging 5.5% in the Last Week Alone - 富途牛牛
Aurinia Pharmaceuticals Inc (AUPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
1.06%
자본화:
|
볼륨(24시간):